Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mai H. ElNaggar, Abdullah A. Elgazar, Ghada Gamal, Shimaa M. Hamed, Zainab M. Elsayed, Mohamed K. El-Ashrey, Amira Abood, Mahmoud A. El Hassab, Ahmed M. Soliman, Ramadan A. El-Domany, Farid A. Badria, Claudiu T. Supuran & Wagdy M. Eldehna. (2023) Identification of sulphonamide-tethered N-((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Clemente Capasso & Claudiu T. Supuran. (2023) The management of Babesia, amoeba and other zoonotic diseases provoked by protozoa. Expert Opinion on Therapeutic Patents 33:3, pages 179-192.
Read now
Read now
Claudiu T. Supuran. (2023) Antiprotozoal drugs: challenges and opportunities. Expert Opinion on Therapeutic Patents 33:3, pages 133-136.
Read now
Read now
Alessio Nocentini, Clemente Capasso & Claudiu T. Supuran. (2022) Perspectives on the design and discovery of α-ketoamide inhibitors for the treatment of novel coronavirus: where do we stand and where do we go?. Expert Opinion on Drug Discovery 17:6, pages 547-557.
Read now
Read now
Articles from other publishers (3)
Claudiu T. Supuran. (2023) Progress of Section “Biochemistry” in 2022. International Journal of Molecular Sciences 24:6, pages 5873.
Crossref
Crossref
Federico Ricci, Rosaria Gitto, Giovanna Pitasi & Laura De Luca. (2022) In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets. Biomolecules 12:4, pages 482.
Crossref
Crossref
Alane Beatriz Vermelho, Mattia Mori, William A. Donald & Claudiu T. Supuran. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery
321
329
.